BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Li Z, Yang L, Lei H, Yu H, Liao Z, Zhou F, Xie C, Zhou Y. Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status. J Cancer Res Clin Oncol 2015;141:1545-52. [DOI: 10.1007/s00432-015-1911-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Orun O, Tiber PM, Serakinci N. Partial knockdown of TRF2 increase radiosensitivity of human mesenchymal stem cells. International Journal of Biological Macromolecules 2016;90:53-8. [DOI: 10.1016/j.ijbiomac.2015.10.072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
2 Wang Z, Wu X. Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review). Oncol Rep 2021;46:184. [PMID: 34278498 DOI: 10.3892/or.2021.8135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen B, Zhang Y, Yang Y, Chen S, Xu A, Wu L, Xu S. Involvement of telomerase activity inhibition and telomere dysfunction in silver nanoparticles anticancer effects. Nanomedicine (Lond) 2018;13:2067-82. [PMID: 30203702 DOI: 10.2217/nnm-2018-0036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Matsuya Y, Kimura T, Date H. Markov chain Monte Carlo analysis for the selection of a cell-killing model under high-dose-rate irradiation. Med Phys 2017;44:5522-32. [PMID: 28786486 DOI: 10.1002/mp.12508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
5 Barczak W, Sobecka A, Golusinski P, Masternak MM, Rubis B, Suchorska WM, Golusinski W. hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification. Sci Rep 2018;8:5949. [PMID: 29654294 DOI: 10.1038/s41598-018-24503-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Benhamou Y, Picco V, Pagès G. The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma. Oral Oncol 2016;57:46-53. [PMID: 27208844 DOI: 10.1016/j.oraloncology.2016.04.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
7 Assani G, Xiong Y, Zhou F, Zhou Y. Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity. Oncotarget 2018;9:35008-25. [PMID: 30405890 DOI: 10.18632/oncotarget.26150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Gao X, Wang W, Yang H, Wu L, He Z, Zhou S, Zhao H, Fu Z, Zhou F, Zhou Y. UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo. Oncotarget 2016;7:32543-53. [PMID: 27105523 DOI: 10.18632/oncotarget.8869] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
9 Polito F, Cucinotta M, Abbritti RV, Brogna A, Pergolizzi S, Tomasello C, Barresi V, Angileri FF, Di Giorgio R, Conti A, La Torre D, Germanò A, Aguennouz M. Silencing of telomere-binding protein adrenocortical dysplasia (ACD) homolog enhances radiosensitivity in glioblastoma cells. Transl Res 2018;202:99-108. [PMID: 30080989 DOI: 10.1016/j.trsl.2018.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Berardinelli F, Coluzzi E, Sgura A, Antoccia A. Targeting telomerase and telomeres to enhance ionizing radiation effects in in vitro and in vivo cancer models. Mutat Res Rev Mutat Res 2017;773:204-19. [PMID: 28927529 DOI: 10.1016/j.mrrev.2017.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]